269 results on '"Coombes, R.C."'
Search Results
2. Epirubicin dose and sequential hormonal therapy—Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer
3. Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)—first results from PathIES
4. An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)
5. A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy
6. 33P The multi-switching activity of circulatory neutrophils in patients with early breast cancer
7. Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen
8. Prevalence of ctDNA in early screen-detected breast cancers using highly sensitive and specific dual molecular barcoded personalised mutation assays
9. 29P The multi-switching activity of circulatory neutrophils in patients with early breast cancer
10. Longitudinal whole-exome sequencing of cell-free DNA for tracking the co-evolutionary tumor and immune evasion dynamics: longitudinal data from a single patient
11. Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)—first results from PathIES†
12. 230MO First in human, modular study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in patients with advanced solid malignancies
13. 265P Study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in combination with fulvestrant in patients with advanced hormone receptor positive HER2 negative breast cancer (HR+BC)
14. The clinical significance of radiologically detected silent pulmonary nodules in early breast cancer
15. 176P Breast cancer treatment during the first wave of the COVID-19 pandemic at a UK centre
16. Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
17. Long-term follow-up of a randomised trial designed to determine the need for irradiation following conservative surgery for the treatment of invasive breast cancer
18. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
19. Longitudinal whole-exome sequencing of cell-free DNA unravels the metastatic evolutionary dynamics of BRCA2-mutated breast cancer
20. High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial
21. 55O_PR - Prognostic and Predictive Value of IHC4 and ERB1 in the Intergroup Exemestane Study (IES) - On Behalf of the Pathies Investigators
22. Estrogen-receptor-directed neoadjuvant therapy for breast cancer: Results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy
23. Retroviral infection of the FGF2 gene into MCF-7 cells induces branching morphogenesis, retards cell growth and suppresses tumorigenicity in nude mice
24. Design and Rationale of a Randomised Comparison of Cyclophosphamide, Methotrexate and Fluorouracil vs Fluorouracil, Epirubicin and Cyclophosphamide in Node-Positive Premenopausal Women with Operable Breast Cancer: A Trial of the International Collaborative Cancer Group (ICCG)
25. Lactic acidosis: a presentation of metastatic breast cancer arising in pregnancy
26. Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen
27. Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
28. Anastrozole shows evidence of activity in postmenopausal patients who have responded or stabilised on formestane therapy
29. Prognostic and predictive value of ER beta 1 and ER beta 2 in the Intergroup Exemestane Study (IES)-first results from PathIES(aEuro)
30. Diagnosing breast carcinoma in young women
31. EFFECT OF 1αHYDROXYVITAMIN D3 ON GROWTH OF NITROSOMETHYLUREA-INDUCED RAT MAMMARY TUMORS.
32. Micrometastases in Breast Cancer
33. Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years
34. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer:Intergroup Exemestane Study
35. Prognostic and Predictive Value of IHC4 and ERB1 in the Intergroup Exemestane Study (IES) - On Behalf of the Pathies Investigators
36. FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines
37. Topical calcipotriol treatment in advanced breast cancer
38. Gene ICE as Applied to Studies of Hormonally-Responsive Cancers
39. Patey Prize 07
40. The effect of oestrogen and tamoxifen on purified normal and malignant human primary breast epithelial cells
41. The effect of adjuvant treatment on minimal residual disease (MRD) in patients with primary breast cancer: 2 years follow-up data
42. Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer
43. Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer
44. Epirubicin Plus Tamoxifen Versus Tamoxifen Alone in Node-Positive Postmenopausal Patients With Breast Cancer: A Randomized Trial of the International Collaborative Cancer Group
45. XR3054, structurally related to limonene, is a novel inhibitor of farnesyl protein transferase
46. Docetaxel: response in patients who have received at least two prior chemotherapy regimes for metastatic breast cancer
47. S27 Aromatase inhibitors and their role in the adjuvant treatment strategy
48. 0-71. Combination rivizor® (vorozole) and ZoladexTM (goserelin) in premenopausal breast cancer: towards maximal oestrogen deprivation
49. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19
50. A Pilot study to evaluate paclitaxel (Taxol™) as primary medical treatment for patients with inoperable stage III and IV breast carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.